235 related articles for article (PubMed ID: 11777556)
1. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans.
Lenzlinger PM; Marx A; Trentz O; Kossmann T; Morganti-Kossmann MC
J Neuroimmunol; 2002 Jan; 122(1-2):167-74. PubMed ID: 11777556
[TBL] [Abstract][Full Text] [Related]
2. Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury.
Ertel W; Keel M; Stocker R; Imhof HG; Leist M; Steckholzer U; Tanaka M; Trentz O; Nagata S
J Neuroimmunol; 1997 Dec; 80(1-2):93-6. PubMed ID: 9413263
[TBL] [Abstract][Full Text] [Related]
3. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients.
Ciusani E; Frigerio S; Gelati M; Corsini E; Dufour A; Nespolo A; La Mantia L; Milanese C; Massa G; Salmaggi A
J Neuroimmunol; 1998 Feb; 82(1):5-12. PubMed ID: 9526840
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex.
Sabri F; De Milito A; Pirskanen R; Elovaara I; Hagberg L; Cinque P; Price R; Chiodi F
J Neuroimmunol; 2001 Mar; 114(1-2):197-206. PubMed ID: 11240032
[TBL] [Abstract][Full Text] [Related]
5. Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus.
Felderhoff-Mueser U; Herold R; Hochhaus F; Koehne P; Ring-Mrozik E; Obladen M; Bührer C
Arch Dis Child; 2001 Apr; 84(4):369-72. PubMed ID: 11259245
[TBL] [Abstract][Full Text] [Related]
6. Markers for cell-mediated immune response are elevated in cerebrospinal fluid and serum after severe traumatic brain injury in humans.
Lenzlinger PM; Hans VH; Jöller-Jemelka HI; Trentz O; Morganti-Kossmann MC; Kossmann T
J Neurotrauma; 2001 May; 18(5):479-89. PubMed ID: 11393251
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of apoptosis in cerebrospinal fluid of patients with severe head injury.
Uzan M; Erman H; Tanriverdi T; Sanus GZ; Kafadar A; Uzun H
Acta Neurochir (Wien); 2006 Nov; 148(11):1157-64; discussion. PubMed ID: 16964558
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury.
Stahel PF; Morganti-Kossmann MC; Perez D; Redaelli C; Gloor B; Trentz O; Kossmann T
J Neurotrauma; 2001 Aug; 18(8):773-81. PubMed ID: 11526983
[TBL] [Abstract][Full Text] [Related]
9. Soluble fas levels correlate with multiple organ dysfunction severity, survival and nitrate levels, but not with cellular apoptotic markers in critically ill patients.
Papathanassoglou ED; Moynihan JA; Vermillion DL; McDermott MP; Ackerman MH
Shock; 2000 Aug; 14(2):107-12. PubMed ID: 10947151
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
[TBL] [Abstract][Full Text] [Related]
11. CSF soluble Fas correlates with the severity of HIV-associated dementia.
Towfighi A; Skolasky RL; St Hillaire C; Conant K; McArthur JC
Neurology; 2004 Feb; 62(4):654-6. PubMed ID: 14981191
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal expression of proteins regulating apoptosis in acute stroke.
Tarkowski E; Rosengren L; Blomstrand C; Jensen C; Ekholm S; Tarkowski A
Stroke; 1999 Feb; 30(2):321-7. PubMed ID: 9933267
[TBL] [Abstract][Full Text] [Related]
13. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.
Csuka E; Morganti-Kossmann MC; Lenzlinger PM; Joller H; Trentz O; Kossmann T
J Neuroimmunol; 1999 Nov; 101(2):211-21. PubMed ID: 10580806
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of soluble Fas receptor and Fas ligand in the cerebrospinal fluid of HIV-infected patients.
Sporer B; Koedel U; Goebel FD; Pfister HW
AIDS Res Hum Retroviruses; 2000 Feb; 16(3):221-6. PubMed ID: 10710210
[TBL] [Abstract][Full Text] [Related]
15. Plasma soluble fas and soluble fas ligand in chronic glomerulonephritis.
Sano H; Asano K; Minatoguchi S; Hiraoka J; Fujisawa K; Nishigaki K; Yasuda N; Kumada H; Takemura M; Ohashi H; Seishima M; Fujiwara T; Fujiwara H
Nephron; 1998 Oct; 80(2):153-61. PubMed ID: 9736812
[TBL] [Abstract][Full Text] [Related]
16. Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.
Santarsieri M; Kumar RG; Kochanek PM; Berga S; Wagner AK
Brain Behav Immun; 2015 Mar; 45():15-27. PubMed ID: 25218898
[TBL] [Abstract][Full Text] [Related]
17. Transient rise in serum soluble Fas (APO-1/CD95) in patients undergoing cardiac surgery.
Kawahito K; Misawa Y; Fuse K
Artif Organs; 2000 Aug; 24(8):628-31. PubMed ID: 10971250
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
[TBL] [Abstract][Full Text] [Related]
19. Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels.
Bruserud O; Ulvestad E
Cancer Immunol Immunother; 2000 Sep; 49(7):377-87. PubMed ID: 10999464
[TBL] [Abstract][Full Text] [Related]
20. Modulation of sFas indicates apoptosis in human herpes simplex encephalitis.
Sabri F; Granath F; Hjalmarsson A; Aurelius E; Sköldenberg B
J Neuroimmunol; 2006 Feb; 171(1-2):171-6. PubMed ID: 16325272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
